NFKB1 and neoplasm: In neutrophils, eosinophils, MCs, and macrophages, KMF exerts anti-inflammatory or anti-tumor effects by inhibiting inflammatory signaling pathways, reducing cell infiltration, or regulating polarization states, with mechanisms involving NF-κB, MAPK, and NLRP3 inflammasome.